Cancer risk in patients on dialysis

Lancet

Volumn 354, Issue 9173, 1999, Pages 90-91

  Newstead, Chas G ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; DIALYSIS; FOLLOW UP; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; NOTE; PRIORITY JOURNAL;

EID: 0033542884     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)00207-X     Document Type: Note

References (12)

1. Newstead C.G. Assessment of risk of cancer after renal transplantation. Lancet. 351:1998;610-611.
2. Chantrel Enache I., Bouiller M.et al. Abysmal prognosis of patients with type 2 diabetes entering dialysis. Nephrol Dial Transplant. 14:1999;129-136.
3. Vamvakas S., Bahner U., Heidland A. Increased cancer incidence in terminal kidney failure: potential pathogenetic mechanisms [in German]. Schweitz Med Wochenschr. 127:1997;597-604.
4. Kincaid Smith P. Analgesic nephropathy and the effect of non-steroidal anti-inflammatory drugs on the kidney. Catto G.R.D. Drugs and the kidney. 1989;1-35 Kluwer Academic Publishers, Lancaster.
5. Taylor J.S. Carcinoma of the urinary tract and analgesic abuse. Med J Aust. i:1972;407-409.
6. Swindle P., Falk M., Rigby R., Petrie J., Hawley C., Nicol D. Transitional cell carcinoma in renal transplant recipients: the influence of compound analgesics. Br J Urol. 81:1998;229-233.
7. Bukvic D., Velimirovic D., Maric I.et al. Urinary system tumors in patients with endemic nephropathy on chronic hemodialysis [in Serbo-Croatian]. Srp Arh Celok Lek. 124(1):1996;181-183.
8. Kliem V., Thon W., Krautzig S.et al. High mortality from urothelial carcinoma despite regular tumor screening in patients with analgesic nephropathy after renal transplantation. Transpl Int. 9:1996;231-235.
9. Levine E. Acquired cystic kidney disease. Radiol Clin North Am. 34:1996;947-964.
10. Curtis J.J. End-stage renal disease patients: referral for transplantation. J Am Soc Nephrol. 9:1998;137-140.
11. Raine A.E.G., Margreiter R., Brunner F.P.et al. Report on management of renal failure in Europe XXII, 1991. Nephrol Dial Transplant. 7(2):1992;7-35.
12. Chertow G.M., Paltiel A.D., Owen W.F. Jr., Lazarus J.M. Cost-effectiveness of cancer screening in end-stage renal disease. Arch Intern Med. 156:1996;1345-1350.